U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. Public Meeting on Patient-Focused Drug Development for Stimulant Use Disorder - 03/10/2020 - 03/10/2020
  1. News & Events for Human Drugs

Meeting

Event Title
Public Meeting on Patient-Focused Drug Development for Stimulant Use Disorder
March 10, 2020


Date:
March 10, 2020
Time:
12:30 PM - 05:00 PM EDT

Location: Attend online or in person at:
Silver Spring Civic Building
1 Veterans Plaza, Silver Spring, MD 20910

 

Save the Date

Registration to open in 2020

Meeting materials will be posted closer to the event date

You may attend in-person or virtually. This event is FREE.

 

About This Event

On March 10, 2020, FDA is hosting a public meeting on Patient-Focused Drug Development for Stimulant Use Disorder. This meeting will provide FDA the opportunity to obtain input from individuals with stimulant use disorder and other stakeholders on the impact of stimulant use disorder and views on treatment goals and approaches. In particular, FDA is interested in hearing perspectives from individuals with stimulant use disorder on the:

  • Health effects and daily impacts of their condition
  • Impact (if any) of opioid and polysubstance use on their condition
  • Treatment goals
  • Decision factors considered when seeking out or selecting a treatment